Masimo terminates EVP Business Development Tao Levy as part of healthcare refocus

MASIMO CORP

Terminated Tao Levy, EVP Business Development, effective November 13, 2024.
Termination part of strategic shift to refocus on core healthcare business.
No replacement named; Levy's departure is involuntary.
Levy was responsible for business development activities.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Tao Levy

Executive Vice President, Business Development

MASI · MASIMO CORP

Effective: 2024-11-13
Filed: November 18, 2024, 6:59 PM ET

On November 13, 2024, in connection with its strategic shift to refocus on its core healthcare business, Masimo Corporation (the “ Company ”) terminated the employment of Tao Levy, the Company’s Executive Vice President, Business Development.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Tao Levy was terminated as Executive Vice President, Business Development at MASIMO CORP.

Action: terminated
Role: Executive Vice President, Business Development

Exact text from the filing

On November 13, 2024, in connection with its strategic shift to refocus on its core healthcare business, Masimo Corporation (the “ Company ”) terminated the employment of Tao Levy, the Company’s Executive Vice President, Business Development.

View on SEC.gov

MASIMO CORP filing history →

Source: SEC EDGAR

accession 0000937556-24-000118

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.